Marietta Wealth Management’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $6.01M | Buy |
11,451
+673
| +6% | +$353K | 0.78% | 61 |
|
|
2025
Q1 | $6.84M | Buy |
10,778
+2,501
| +30% | +$1.59M | 1% | 40 |
|
|
2024
Q4 | $5.9M | Buy |
8,277
+624
| +8% | +$444K | 0.85% | 52 |
|
|
2024
Q3 | $8.05M | Buy |
7,653
+29
| +0.4% | +$30.5K | 1.17% | 30 |
|
|
2024
Q2 | $8.01M | Sell |
7,624
-88
| -1% | -$92.5K | 1.25% | 24 |
|
|
2024
Q1 | $7.42M | Sell |
7,712
-141
| -2% | -$136K | 1.23% | 29 |
|
|
2023
Q4 | $6.9M | Buy |
7,853
+20
| +0.3% | +$17.6K | 1.23% | 30 |
|
|
2023
Q3 | $6.45M | Sell |
7,833
-207
| -3% | -$170K | 1.28% | 26 |
|
|
2023
Q2 | $5.78M | Buy |
8,040
+120
| +2% | +$86.2K | 1.09% | 37 |
|
|
2023
Q1 | $6.51M | Sell |
7,920
-288
| -4% | -$237K | 1.38% | 22 |
|
|
2022
Q4 | $5.92M | Sell |
8,208
-333
| -4% | -$240K | 1.34% | 26 |
|
|
2022
Q3 | $5.88M | Sell |
8,541
-366
| -4% | -$252K | 1.47% | 23 |
|
|
2022
Q2 | $5.27M | Buy |
8,907
+108
| +1% | +$63.8K | 1.27% | 29 |
|
|
2022
Q1 | $6.15M | Buy |
8,799
+619
| +8% | +$432K | 1.29% | 29 |
|
|
2021
Q4 | $5.17M | Buy |
8,180
+996
| +14% | +$629K | 1.04% | 41 |
|
|
2021
Q3 | $4.35M | Buy |
7,184
+2,415
| +51% | +$1.46M | 0.95% | 43 |
|
|
2021
Q2 | $2.66M | Buy |
4,769
+265
| +6% | +$148K | 0.6% | 67 |
|
|
2021
Q1 | $2.13M | Buy |
+4,504
| New | +$2.13M | 0.53% | 72 |
|